Cipla’sZAR4.5bn(c.US$512m)acquisitionofanAfricanpharmabusiness

In one of the largest single investments by an Indian company on the African continent, RMB is proud to have acted as merchant bank, guarantee provider and FX counterparty for Cipla India's acquisition of 100% of Cipla Medpro South Africa. The deal strengthens Cipla Medpro's position in South Africa and supports its expansion into Africa, giving the continent access to a wider range of affordable medicines.